116 results on '"Schmidt, Warren"'
Search Results
2. An Updated Look at the Values and Expectations of Federal Government Executives
3. DEVELOPMENT OF A RAPID PROTOTYPING SYSTEM FOR TACTILE GRAPHICS PRODUCTION
4. How to Choose a Leadership Pattern
5. Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity*
6. Zinc Protoporphyrin Binding to Telomerase Complexes and Inhibition of Telomerase Activity
7. Correction to: Modification of the third phase in the framework for vertebrate species persistence in urban mosaic environments
8. Modification of the third phase in the framework for vertebrate species persistence in urban mosaic environments
9. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
10. Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders
11. Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
12. Invasive amphibians in southern Africa: A review of invasion pathways
13. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo
14. HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes
15. Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
16. Su1501 Assessment of Gastric Mucosal Injury in Patients With Cirrhosis
17. Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
18. Antibodies to Chromosomal Non-Histone Proteins in Malignant Cells
19. Direct-Acting Antiviral Agents and the Path to Interferon Independence
20. Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]
21. Restoration of Type I Interferon Expression by Heme and Related Tetrapyrroles Through Inhibition of NS3/4A Protease
22. Heme and HO-1 Inhibition of HCV, HBV, and HIV
23. Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
24. FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program
25. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans
26. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
27. Portosystemic Encephalopathy Due to Mesoiliac Shunt in a Patient Without Cirrhosis
28. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells
29. Increased plasma nitric oxide, L‐arginine, and arginase‐1 in cirrhotic patients with progressive renal dysfunction
30. 831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3
31. Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
32. Reply
33. Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?
34. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury
35. S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment
36. W1710 Decreased Expression of Peripheral IL-10 mRNA and Deregulation of Immunoregulatory Function in Patients with Decompensated Cirrhosis
37. S1000 Results from the Epic3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the RE-Treatment of Previous Interferon/Ribavirin Non-Responders (Nr)
38. Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity
39. Older Donor Livers Show Early Severe Histological Activity, Fibrosis, and Graft Failure After Liver Transplantation for Hepatitis C
40. Increased hepatic telomerase activity in a rat model of iron overload: A role for altered thiol redox state?
41. Treatment of hepatitis C cryoglobulinemia: Mission and challenges
42. National Multicenter Study of HIV Testing and HIV Seropositivity in Patients With Chronic Hepatitis C Virus Infection
43. Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
44. Positive Serum Cryoglobulin Is Associated with Worse Outcome after Liver Transplantation for Chronic Hepatitis C
45. Hepatitis C virus‐core and non structural proteins lead to different effects on cellular antioxidant defenses
46. Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver
47. GB Virus Type C NS5A Sequence Polymorphisms: Association with Interferon Susceptibility and Inhibition of PKR-Mediated eIF2α Phosphorylation
48. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis
49. Down‐Regulation of Heme Oxygenase–1 by Hepatitis C Virus Infection In Vivo and by the In Vitro Expression of Hepatitis C Core Protein
50. Seronegative Hepatitis C Virus Infection, Not Just RNA Detection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.